Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Top 5 Marijuana Stocks for 2019
With individual stock selection now more critical than ever, this report is designed to bring you some of our top ideas in the marijuana industry this year.
One of the companies highlighted in this report offers a life-changing therapy that reduces the number of seizures in children with two rare types of childhood-onset epilepsy. It has the potential for the stock to sky-rocket. You need to find out the name of this company before the rest of the market does.
P.S. Not many retail investors pay attention to the marijuana sector. Use this complimentary guide and get a head start on your path to profiting from the booming cannabis industry!
Menu

Pivot Pharmaceuticals Inc (PVOTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 29,264
  • Shares Outstanding, K 88,679
  • Annual Sales, $ 0 K
  • Annual Income, $ -120 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/07/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0160 +1,937.50%
on 03/28/19
0.3542 -7.96%
on 04/24/19
+0.1712 (+110.59%)
since 03/22/19
3-Month
0.0160 +1,937.50%
on 03/28/19
0.3542 -7.96%
on 04/24/19
+0.1443 (+79.42%)
since 01/24/19
52-Week
0.0160 +1,937.50%
on 03/28/19
0.6400 -49.06%
on 05/21/18
-0.0740 (-18.50%)
since 04/24/18

Most Recent Stories

More News
Pivot Pharma Announces C$15 million Private Placement and Strategic Partnership

Joe Mimran to Join Advisory Committee; Krisztian Toth Appointed to Board of Directors

PVOTF : 0.3260 (-1.21%)
PVOT.CN : 0.450 (+3.45%)
IIROC Trade Resumption - PVOT

Trading resumes in:

PVOTF : 0.3260 (-1.21%)
Pivot Pharma Announces C$15 million Private Placement and Strategic Partnership

Joe Mimran to Join Advisory Committee; Krisztian Toth Appointed to Board of Directors

PVOTF : 0.3260 (-1.21%)
Pivot Pharma Announces C$15 million Private Placement and Strategic Partnership

Joe Mimran to Join Advisory Committee; Krisztian Toth Appointed to Board of Directors

PVOTF : 0.3260 (-1.21%)
Pivot Completes C$590,000 Non-Brokered Private Placement

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has closed a non-brokered Private Placement (the "Private Placement") for a total...

PVOTF : 0.3260 (-1.21%)
IIROC Trading Halt - PVOT

The following issues have been halted by IIROC:

PVOTF : 0.3260 (-1.21%)
IIROC Trade Resumption - PVOT

Trading resumes in:

PVOTF : 0.3260 (-1.21%)
Pivot Pharma Signs Letter of Intent with Pharmascience Inc.

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Letter of Intent, dated February 26(th), 2019, with Pharmascience...

PVOTF : 0.3260 (-1.21%)
Pivot Pharma Signs Letter of Intent with Pharmascience Inc.

VANCOUVER , April 3, 2019 /PRNewswire/ - Pivot Pharmaceuticals Inc . (CSE: PVOT / OTCQB: PVOTF  / FRA: NPAT ) ("Pivot" or the "Company") is pleased to announce that it has signed...

PVOTF : 0.3260 (-1.21%)
IIROC Trading Halt - PVOT

The following issues have been halted by IIROC:

PVOTF : 0.3260 (-1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

See More Share

Trade PVOTF with:

Key Turning Points

2nd Resistance Point 0.3833
1st Resistance Point 0.3567
Last Price 0.3260
1st Support Level 0.2967
2nd Support Level 0.2633

See More

52-Week High 0.6400
Fibonacci 61.8% 0.4016
Fibonacci 50% 0.3280
Last Price 0.3260
Fibonacci 38.2% 0.2544
52-Week Low 0.0160

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar